We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$110B
AUM Growth
+$10.8B
Cap. Flow
+$4.52B
Cap. Flow %
4.11%
Top 10 Hldgs %
23.63%
Holding
4,320
New
332
Increased
2,194
Reduced
1,423
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 14.49%
2 Financials 8.91%
3 Healthcare 8.14%
4 Industrials 6.57%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOR
3851
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$79K ﹤0.01%
+88
New +$67.3K
BKCC
3852
DELISTED
BlackRock Capital Investment Corporation
BKCC
$77K ﹤0.01%
19,502
-85
-0.4% -$335
BBBY
3853
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
$77K ﹤0.01%
13,000
CCO icon
3854
Clear Channel Outdoor Holdings
CCO
$1.23B
$76K ﹤0.01%
28,890
+2,490
+9% +$5.97K
BKEP
3855
DELISTED
Blueknight Energy Partners L.P.
BKEP
$76K ﹤0.01%
+20,000
New +$71.7K
BMY icon
3856
CALL
Bristol-Myers Squibb
BMY
$132B
$73K ﹤0.01%
79,900
+53,400
+202% +$3.48M
SNCR
3857
DELISTED
Synchronoss Technologies
SNCR
$73K ﹤0.01%
2,262
+733
+48% +$20.6K
BRY
3858
DELISTED
Berry Corp
BRY
$71K ﹤0.01%
+10,583
New +$67K
CVX icon
3859
CALL
Chevron
CVX
$382B
$71K ﹤0.01%
78,400
-5,600
-7% -$591K
MPLX icon
3860
CALL
MPLX
MPLX
$59.5B
$71K ﹤0.01%
46,200
-3,500
-7% -$99.1K
QTNT
3861
DELISTED
Quotient Limited Ordinary Shares
QTNT
$71K ﹤0.01%
486
+51
+12% +$8.15K
CARM
3862
DELISTED
Carisma Therapeutics
CARM
$70K ﹤0.01%
761
-1,109
-59% -$70.7K
NEWP
3863
New Pacific Metals
NEWP
$1.16B
$70K ﹤0.01%
+14,500
New +$76.4K
UONEK icon
3864
Urban One Class D
UONEK
$24.5M
$70K ﹤0.01%
+1,400
New +$49.1K
EPM icon
3865
Evolution Petroleum
EPM
$134M
$69K ﹤0.01%
+13,893
New +$54.6K
DNN icon
3866
Denison Mines
DNN
$2.95B
$68K ﹤0.01%
56,140
-20,500
-27% -$24.6K
KMI icon
3867
CALL
Kinder Morgan
KMI
$69.9B
$68K ﹤0.01%
54,000
+1,300
+2% +$23.2K
EOD
3868
Allspring Global Dividend Opportunity Fund
EOD
$286M
$67K ﹤0.01%
11,585
NGL icon
3869
NGL Energy Partners
NGL
$2.14B
$66K ﹤0.01%
27,614
-2,890
-9% -$6.47K
WPRT
3870
PUT
Westport Fuel Systems
WPRT
$35.7M
$66K ﹤0.01%
4,000
+2,000
+100% +$121K
NSL
3871
DELISTED
NUVEEN SENIOR INCM FD
NSL
$65K ﹤0.01%
11,048
-2,560
-19% -$14.6K
WMT icon
3872
CALL
Walmart Inc
WMT
$897B
$63K ﹤0.01%
150,600
-110,700
-42% -$5.16M
CRON
3873
PUT
Cronos Group
CRON
$1.11B
$61K ﹤0.01%
24,100
-2,500
-9% -$20.7K
DWSN icon
3874
Dawson Geophysical
DWSN
$131M
$61K ﹤0.01%
23,550
GLW icon
3875
CALL
Corning
GLW
$136B
$61K ﹤0.01%
53,300
+14,300
+37% +$623K

Similar funds

Raymond James & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Raymond James & Associates held 4,320 positions worth $110B, up 11% from $99.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.52B of net new capital in Q2 2021, opening 332 new positions and adding to 2,194 existing holdings. Its largest new stake was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $175M trimmed.

  • Raymond James & Associates's largest Q2 2021 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $290M increase.
  • Raymond James & Associates's biggest Q2 2021 reduction was Amgen, cutting an estimated $175M.
  • Raymond James & Associates fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $19.1M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $110B portfolio in Q2 2021.
  • Raymond James & Associates opened 332 new positions and closed 241 in Q2 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.